Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.10SEK
−330.30 MSEK
71.46 MSEK
48.31 M
About BIOINVENT INTERNATIONAL AB
Sector
Industry
CEO
Martin Welschof
Website
Headquarters
Lund
Employees (FY)
111
Founded
1997
ISIN
SE0015244520
FIGI
BBG00YJVH3V7
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. Its technology platforms include F.I.R.S.T. and n-CoDeR. The company was founded in 1996 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0H22 is 29.85 SEK — it has increased by 4.01% in the past 24 hours. Watch BIOINVENT INTERNATIONAL AB NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange BIOINVENT INTERNATIONAL AB NPV stocks are traded under the ticker 0H22.
0H22 stock has risen by 18.59% compared to the previous week, the month change is a 38.71% rise, over the last year BIOINVENT INTERNATIONAL AB NPV has showed a 9.45% increase.
We've gathered analysts' opinions on BIOINVENT INTERNATIONAL AB NPV future price: according to them, 0H22 price has a max estimate of 30.00 SEK and a min estimate of 30.00 SEK. Watch 0H22 chart and read a more detailed BIOINVENT INTERNATIONAL AB NPV stock forecast: see what analysts think of BIOINVENT INTERNATIONAL AB NPV and suggest that you do with its stocks.
0H22 reached its all-time high on May 27, 2010 with the price of 690.15 SEK, and its all-time low was 14.35 SEK and was reached on Nov 1, 2023. View more price dynamics on 0H22 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0H22 stock is 3.88% volatile and has beta coefficient of 0.21. Track BIOINVENT INTERNATIONAL AB NPV stock price on the chart and check out the list of the most volatile stocks — is BIOINVENT INTERNATIONAL AB NPV there?
Today BIOINVENT INTERNATIONAL AB NPV has the market capitalization of 1.97 B, it has increased by 6.52% over the last week.
Yes, you can track BIOINVENT INTERNATIONAL AB NPV financials in yearly and quarterly reports right on TradingView.
BIOINVENT INTERNATIONAL AB NPV is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
0H22 net income for the last quarter is −77.95 M SEK, while the quarter before that showed −97.16 M SEK of net income which accounts for 19.77% change. Track more BIOINVENT INTERNATIONAL AB NPV financial stats to get the full picture.
No, 0H22 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2024, the company has 111.00 employees. See our rating of the largest employees — is BIOINVENT INTERNATIONAL AB NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOINVENT INTERNATIONAL AB NPV EBITDA is −362.09 M SEK, and current EBITDA margin is −495.13%. See more stats in BIOINVENT INTERNATIONAL AB NPV financial statements.
Like other stocks, 0H22 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOINVENT INTERNATIONAL AB NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOINVENT INTERNATIONAL AB NPV technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOINVENT INTERNATIONAL AB NPV stock shows the buy signal. See more of BIOINVENT INTERNATIONAL AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.